Zenas BioPharma Q4 EPS $(4.54) Down From $(1.26) YoY

Benzinga Newsdesk www.benzinga.com Negative 97.3%

Neg 97.3% Neu 0% Pos 0%

Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(4.54) per share. This is a 260.32 percent decrease over losses of $(1.26) per share from the same period last year.